AstraZeneca will be approved by the Drug Regulator of India for emergency use of the Coronavirus vaccine developed by Oxford on Friday. This information has been given by sources aware of the case. With this decision, the vaccine will be started in India, the world's second-largest major country.
Over 5 crore doses of AstraZeneca have been prepared by its local manufacturer Serum Institute of India. It has also been reported that vaccine shots will be supplied to various states of India from Cold Stores on Saturday morning.
Let us tell that India has the most cases of Kovid infection after America. The vaccine has already been approved for public use in Britain and Argentina. On the condition of anonymity, two sources have informed that India's Central Drugs Standard Control Organization (CDSCO), whose experts are meeting for the second time this week, can approve the vaccine developed by Bharat Biotech. According to sources, 'AstraZeneca and Bharat Biotech will get approval today.' With today's date in mind, all preparations have been made. Other sources are skeptical about Bharat Biotech. CDSCO's representative refused to give a statement.
Notably, the World Health Organization (WHO) has approved the use of the Kovid-19 Pfizer vaccine by emergency. After this, the poorer countries of the world will also get vaccines. The vaccine is already available in Europe and America. In countries of the world, the drug regulatory agency approves any corona vaccine, but countries with weak systems usually rely on the WHO for this.
The WHO said Thursday that the decision to approve the emergency use of the Corona vaccine would pave the way for countries to import and apply the vaccine. The United Nations health agency said that Pfizer's vaccine had met the safety standards set. It is noteworthy that the American company Pfizer and German company BioNotech jointly developed the vaccine. The vaccine of this company has been approved in many countries of the world including the US, UK, European Union, Canada, and Mexico. These places are being vaccinated. Pfizer's vaccine is kept at very low temperatures, which is a major challenge for developing countries.
